Screener
Corcept Therapeutics CORT Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Short-term marketable securities | 197,158 | 251,657 |
| Trade receivables, net of allowances | 76,920 | 59,786 |
| Inventory | 13,185 | 12,868 |
| Prepaid expenses and other current assets | 41,374 | 40,658 |
| Total current assets | 439,676 | 485,464 |
| Strategic inventory | 18,956 | 11,094 |
| Operating lease right-of-use asset | 6,860 | 4,583 |
| Property and equipment, net | 5,133 | 1,890 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's prepaid & other current?
- Corcept Therapeutics (CORT) reported prepaid & other current of $41.37M in Q2 2026.
- How has Corcept Therapeutics's prepaid & other current changed year-over-year?
- Corcept Therapeutics's prepaid & other current increased by 72.1% year-over-year, from $24.04M to $41.37M.
- What is the long-term trend for Corcept Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Corcept Therapeutics's prepaid & other current has grown at a 43.4% compound annual growth rate (CAGR), from $6.7M to $40.66M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Corcept Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude